Gerovital
, "Fountain of Youth" tablets has as its starting point the
discovery by an Austrian biochemist, Dr Alfred Einhorn, of the substance
"procaine hcl Hydrochloride". In 1905 Einhorn successfully synthesised and
combined in an aqueous solution two products which occur naturally within
the body (Para-aminobenzoic acid- PABA - a member of the B vitamin complex
and Diethylaminoethanol - DEAE).
The
name "procaine hcl" was simply a label Einhorn hung on his work
as a means of distinguishing it. procaine hcl itself proved extremely useful
as an anaesthetic. In America it was known as "Novacaine" and was used
extensively by the dental profession. It was highly effective basically
non-toxic and had no addictive qualities. Despite a similarity of name
procaine hcl has no connection whatsoever with cocaine, indeed Einhorn could
have settled for any one of a number of titles when he was casting around
for a name.
Although
procaine hcl was discovered in 1905 it appears that little further
interest was taken in it beyond its known anaesthetic use until the
late 1940`s when Dr. Ana Aslan of the National Geriatric Institute in
Bucharest, the capital city of Romania, decided to experiment by using
it by means of injection
for the relief of pain in the arthritic joints of elderly patients.
The experiment itself was indeed successful resulting in decreased pain
and increased mobility but, more interestingly the patients began to
exhibit improvements in both physical and mental well-being far beyond
the arthritic benefits.
Ana
Aslan was too good a medical research scientist to allow this
phenomenon to go unnoticed and immediately set up a highly controlled
program into the "side-effects" of procaine in her Gerovital formula.
Basically it was a problem of stabilisation, procaine rapidly hydrolysed
in the body and remained active for a comparatively short time. If it
could be absorbed in greater measure and (hopefully) proportionately
increase the benefits already noticed. Working with her colleagues Dr.
Aslan added potassium metabisulphite and disodium phosphate to the procaine
which had the desired effect of sustaining it within the body for between
6 and 9 hours. In a word GH3 had arrived!

The
"side-effects" of Gerovital GH3 as the new compound became known
became more marked (listed later in the following paragraphs) and the
legend of Bucharest was born. The amount of conclusive evidence as to
its efficacy is prodigious and totally irrefutable - including much
that was carried out by eminent medical authorities in America. It follows
that individuals or organisations (professional or Governmental) who
sought to challenge or ignore the evidence were motivated to do so by
other and less worldly motives, than a desire to benefit Humanity .
There
are of course none so blind as those who do not wish to see,
and we see this time and time again in every aspect of the Humanitarian
cause. In 1956 Ana Aslan presented the research findings to the European
Congress for Gerontology meeting in Karlsruhe, West Germany. Her conclusions
were met with widespread skepticism, the fraternity listened politely
but simply didn't believe, and the reason is not difficult to comprehend.
We have all, lay persons and Medical Professionals alike, been educated
to assume that one takes a single remedy for a single problem - e.g.
an aspirin for headache, another type of powder for stomach ache. For
anyone to suggest, no matter with what sincerity, that a (previously
considered) dental anaesthetic held the secret of the mystery of rejuvenated
cell life was rather more than could be mentally or emotionally digested.
Subscribe to our newsletter
Ana
Aslan had lost the battle - but she had no intention of losing
the war! Intent on proving her case beyond any reasonable doubt she
then embarked on one of the worlds greatest research programs, probably
the largest and most thorough double-blind study ever undertaken in
the history of the health industry. For almost two years 15,000 workers
aged between 38 and 62 years were observed throughout Romania. Over
400 Doctors staffing a network of 154 clinics participated in the program.
All the patients were healthy but ageing and a whole range of astonishing
results were forthcoming. Amongst those using Gerovital sickness diminished
by over 40% (measured in days off work) prompting that Government to
heavily subsidise the distribution of GH3 throughout the population
as an assist to the working economy.
Specifically
blood pressures normalised (either up or down), respiratory
functions improved, muscular vigour increased, basic sex drive increased,
arthritic conditions improved, peptic ulcers disappeared, cholesterol
levels normalised etc etc. In a word the degenerative effects of advancing
age were halted and even reversed to a significant extent in up to 80%
of the subjects under scrutiny. Those who were not receiving GH3 received
a "placebo" instead, but no one - including the medical staff - knew
who was getting which! (hence the term "double-blind"), only the institute
computer held the secret.


During
the study an influenza epidemic swept across Europe and was
no respecter of national boundaries. Communist and Capitalist countries
alike suffered mightily, but whereas the death rate amongst the research
group on Gerovital H3 was 2.7%, amongst those receiving "normal" medical
treatment it was 13.9% - more than 5 times higher! This in itself was
an indication of the heightened level of basic sound good health and
resistance against infection produced by the daily ingestion of this
remarkable food. Dr Aslan was met, again by the European Congress of
Gerontology which carefully examined the mountain of evidence she now
presented and, being convinced of its accuracy, this time accepted it
as a basis for the truth of her conclusions.
Ana Aslan was received warmly and she received tremendous acclaim for
her work.
Independent
testing now took place in a number of countries throughout Western
and Eastern Europe, the United Kingdom and finally America. Where researchers
followed the Aslan method the same astonishing results were forthcoming,
where they did not (and one would be entitled to ask why they did not?)
the results were minimal and were arrived at by a simple ruse of using
only Procaine without the buffering agents. Strangely enough at that
time - and to this day in America - these were the only results widely
published.
In
terms of availability to the general public the (over 400) correct
research programs and results were basically non-existent and once again
it is in order to ask "why"? Unfortunately asking "why" is not a very
profitable occupation as the authorities who went out of their way to
produce false conclusions decrying Gerovital GH3 are not in the business
of explaining themselves and in any event the story does not end at
that point. As far as GH3 was concerned the floodgates were open, country
after country accepted the Aslan findings, often coming to their decisions
after confirming matters through their own research.
As
we look at the situation now over 70 countries have Gerovital
accessible to their people, without prescription, and an estimated fifty
million users have benefited to a greater or lesser degree. In Germany
one of the worlds greatest consumers of alternative and herbal products
a version called KH3 is manufactured (containing half the procaine and
various vitamins) and is now one of the top ten most popular dietary
supplements marketed there. In America a Dr. Sapse who, as an intern
working with Dr. Aslan, never forgot the evidence of his own eyes, approached
the Food and Drug Administration with a view to obtaining pre-market
permission to test the product as an anti-depressant for the elderly.
This was granted and Sapse raised the money to start up his company
(Rom-Amer) to market Gerovital
Ampoules. Unfortunately for him no sooner had he passed GH3 through
Part One (Safety) of the three FDA trials required and was well under
way the F.D.A. changed the rules!
It
seems that wild reports in the media ("The Elixir of Life"),
"Will we live for ever", "Anti-aging miracle" and suchlike
flights of editorial flights of fancy alarmed them to the point of informing
Sapse that he should research the product on a vast number of patients
over a limitless number of years to confirm the claims of the (Newspaper)
media men. In vain did he protest his interest was limited to that of
one factor, they were adamant. The financial implications of this development
were of such horrendous proportions that the good Doctor was literally
stopped in his tracks and his company bankrupted.
It
is of course intriguing to conjecture why the F.D.A did this
considering that Sapse had restricted himself entirely to the natural
anti-depressant aspect of Gerovital GH3 and that the Authority itself
had already decided there was no safety problem with the product (based
on American research) - an opinion they maintain to this day. Perhaps
as with many bureaucratic institutions, the F.D.A. saw itself operating
at a higher level than mere public interest, perhaps it saw no requirement
to explain its actions to those humdrum members of society whose lot
it was to support. We are left therefore in the position of having to
decide for ourselves what the truth may be; one opinion is expressed
thus. If we take as a standpoint the fact that Gerovital GH3 works -
and research provides overwhelming evidence that it does, we then have
to consider what effect this seemingly beneficial nutrient would have
were it to be also generally available world-wide (not just accessible,
as has been the case for some 20 years in many developed countries world-wide)
- including the communist block where there is no money to be made from
discoveries of this nature as all health industry is state run and state
owned.
The
key to the riddle lies in the known fact that GH3 does work,
not only that but it works - "across the board" - on a number of seemingly
unrelated conditions and that these conditions are presently being "treated"
(for want of a better word) by an ever increasing range of highly expensive
unnatural drugs which produce an ever increasing range of hideous side-effects
which are then treated by more unnatural drugs - which produce more
side-effects, which are then treated by …etc …etc.
To
put the matter into simple and accurate perspective, if true
formula Gerovital GH3 was easily marketable to the public it would strike
a monumental blow at the lucrative synthetic drug industry, an industry
which in size, scope and revenue is second only to the Oil and Arms
industries. It is well known that the suppression of competing products
and materials has long been commonplace in all large industries world-wide.
For years the recording tape was held up by the disc manufacturers as
it would have decimated their business. Similarly the "Pogue" carburettor,
patented in 1933 and giving 204 miles per gallon when fitted to a gas
guzzling Ford L.T.D. - with greater power, vanished off the scene as
soon as mention was made of it in the press. However we cannot isolate
one group as being the only obstructive factor in the case of Gerovital
, they needed help to keep it off the market, they could not do it alone.
To whom should they turn for this help, why to those who have governmental
authority in these matters - The Food and Drug Administration and other
medical authorities.
And
what of the American Medical Association? Why the reluctance
of these powerful entities to carry out swift and accurate research
(using GH3 not just straight procaine) to "satisfy themselves" on what
the rest of the world has known for two decades. Here again we must
suggest perhaps vested interest. And what of the efficacy of the drugs
which the F.D.A. and other medical authorities are so keen to promote
throughout the health industry. Is it not the case that the use of unnatural
drugs has spawned an entire new financial bonanza. One whereby the long
suffering public is now prescribed lethal and near lethal substances
to "treat symptoms" rather than receiving help to cure their conditions!
Any patient who is continually receiving highly expensive treatment
for his symptoms is worth much more to the medical industry than one
who is cured. It's a fair question to ask - where do the Medical Associations
stand in the matter of Gerovital GH3? The answer is they don't, they
have done a highly professional job of ignoring it totally, in stark
and shameful contrast to their more enlightened brethren.
Readers
have to decide for themselves. None of the participants are
likely to explain their actions so it remains a matter of opinion. Our
grateful thanks to those in whom we place our trust.
Bookmark
this site
Site
Map
The
information provided herein should not be used for diagnosis or treatment
of any medical condition. It it provided for educational purposes
only. A licensed physician should be consulted for diagnosis and treatment
of any and all medical conditions. millenniumh.com does not warrant
that the information is free from all errors and omissions. millenniumh.com
does not recommend, advise or suggest that any physician or other
health care provider use the information as a sole resource for diagnostic
or educational purposes. Millenniumh.com does not warrant that the
information meets any particular standard. Having said all that, remember
that this information is provided in good faith as a free service
to you, the Internet browser. We are glad that you have visited Millenniumh.com
and hope you come by often.